FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced that it has been invited to present at the Sanders Morris Harris Middle Market Investor Growth Conference. The conference is being held on October 23-24, 2006, at the Omni Berkshire Place Hotel in New York and will be attended by securities analysts, fund managers and institutional investors.
